{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:24:59Z","timestamp":1788942299499,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.urolonc.2011.07.016","type":"journal-article","created":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T06:06:16Z","timestamp":1315980376000},"page":"909-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols?"],"prefix":"10.1016","volume":"31","author":[{"given":"Nikhil","family":"Vasdev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2011.07.016_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.292.6521.681","article-title":"Importance of occult hematuria found at screening","volume":"292","author":"Ritchie","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.urolonc.2011.07.016_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-5347(17)40763-4","article-title":"The significance of adult hematuria: 1,000 Hematuria evaluations including a risk-benefit and cost-effectiveness analysis","volume":"141","author":"Mariani","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.07.016_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-410X.2006.05976.x","article-title":"A prospective analysis of the diagnostic yield resulting from the attendance of 4,020 patients at a protocol-driven hematuria clinic","volume":"97","author":"Edwards","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.07.016_bib4","doi-asserted-by":"crossref","first-page":"a3021","DOI":"10.1136\/bmj.a3021","article-title":"Assessment and management of non-visible hematuria in primary care","volume":"338","author":"Kelly","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2011.07.016_bib5","doi-asserted-by":"crossref","DOI":"10.3310\/hta10180","article-title":"Diagnostic tests and algorithms used in the investigation of hematuria: Systematic reviews and economic evaluation","volume":"10","author":"Rodgers","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urolonc.2011.07.016_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-5347(05)67916-5","article-title":"A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.07.016_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-5347(17)39379-5","article-title":"Strategies for asymptomatic microscopic hematuria: A prospective study of 1,034 patients","volume":"144","author":"Murakami","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.07.016_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1464-410X.2002.03053.x","article-title":"\u2018Superficial\u2019 bladder cancer\u2014time to uncouple pT1 tumours from pTa tumors","volume":"90","author":"Bryan","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.07.016_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1442-2042.2006.01219.x","article-title":"Bacteriuria, Peoria and bacteremia frequency following outpatient cystoscopy","volume":"13","author":"Turan","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2011.07.016_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1464-410X.2007.07093.x","article-title":"Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy","volume":"100","author":"Johnson","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.07.016_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1464-410X.2002.02776.x","article-title":"Delay and survival in bladder cancer","volume":"89","author":"Wallace","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.07.016_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0090-4295(00)01124-9","article-title":"A new diagnostic algorithm for the evaluation of microscopic hematuria","volume":"57","author":"Jaffe","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.07.016_bib14","first-page":"701","article-title":"Tobacco use, occupation, coffee, various nutrients, and bladder cancer","volume":"64","author":"Howe","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2011.07.016_bib15","first-page":"3853","article-title":"Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder","volume":"48","author":"Kantor","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2011.07.016_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/oxfordjournals.aje.a114430","article-title":"Life-style and occupational risk factors in cancer of the lower urinary tract","volume":"124","author":"Claude","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1A","key":"10.1016\/j.urolonc.2011.07.016_bib17","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0002-9343(02)01053-7","article-title":"Scientific and clinical challenges in the management of urinary tract infections","volume":"113","author":"Stamm","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.urolonc.2011.07.016_bib18","first-page":"839","article-title":"Urinary tract diseases and bladder cancer risk: A case-control study","volume":"18","author":"Jhamb","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2011.07.016_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjc.6604889","article-title":"Urinary tract infections and reduced risk of bladder cancer in Los Angeles","volume":"100","author":"Jiang","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2011.07.016_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/aje\/kwh014","article-title":"History of urinary tract infection and risk of renal cell carcinoma","volume":"159","author":"Parker","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2011.07.016_bib21","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/IAI.69.11.6839-6845.2001","article-title":"Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2","volume":"69","author":"Thomas","year":"2001","journal-title":"Gene Infect Immun"},{"key":"10.1016\/j.urolonc.2011.07.016_bib22","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1681\/ASN.2007050611","article-title":"Antimicrobial peptides, innate immunity, and the normally sterile urinary tract","volume":"18","author":"Zasloff","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:25Z","timestamp":1761040885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1078143911002365"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.07.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}